
Richline Pharma Ltd
About Richline Pharma Ltd
Data last updated:
Richline Pharma Ltd is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1992PLC014809.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.18 Cr. It is led by directors including Subba Rao Yarapotina and Vijay Kumar Desa.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 8 – 3 – 977/9/3 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073.
As per MCA filings, the company has open charges of ₹1.75 Cr on record. Court records list 18 cases involving the company, including 11 filed by the company and 5 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8 – 3 – 977/9/3 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Richline Pharma Ltd FY 2020 filings available
Financial Statement Summary of Richline Pharma Ltd
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Richline Pharma Ltd
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Richline Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Richline Pharma Ltd
Richline Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subba Rao Yarapotina | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
| Vijay Kumar Desa | Director | 17 Jan 2007 | 19 Years 8 Months | Current |
| Yerapotina Sri Ramesh Babu | Director | 30 Sep 1992 | 34 Years 0 Months | Current |
Charges & Borrowings of Richline Pharma Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 1996 | Canara Bank | ₹25 Lakh | Open |
| 24 Oct 1995 | Canara Bank | ₹15 Lakh | Open |
| 05 Oct 1995 | Canara Bank | ₹25 Lakh | Open |
| 24 Aug 1994 | Canara Bank | ₹1.1 Cr | Open |
Total charge records: 4 View all charges
Legal Cases of Richline Pharma Ltd
Richline Pharma Ltd has 18 court cases on record: 11 filed by Richline Pharma, 5 filed against it, 2 where it is another party. 1 case is pending and 17 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 2 | 1 |
| District courts | 3 | 3 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Revision petition | Filed against the company by Nettlinx Limited | Disposed |
| High Court for State of Telangana | Court case (CRLP) | Filed by the company against Nettlinx Limited | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Transpek Industry Limited | Disposed |
| High Court for State of Telangana | Company petition | Filed against the company by Bajaj Organics Ltd | Pending |
| High Court for State of Telangana | Writ petition | Company is another party | Disposed |
Full case history
All 18 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Richline Pharma Ltd
Employment history and EPFO contributions of people linked to Richline Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Richline Pharma Ltd
Richline Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1992PLC014809, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1992PLC014809 | Current |
| L24239TG1992PLC014809 | Previous |
| L24239AP1992PLC014809 | Previous |
Recent Activity on Richline Pharma Ltd
Richline Pharma Ltd has 3 board changes on record since 1992: 3 appointments. The latest: Vijay Kumar Desa was appointed as Director on 17 Jan 2007.
Credit Ratings, Litigation & Regulatory Alerts for Richline Pharma Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Richline Pharma Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Richline Pharma Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Richline Pharma Ltd
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Richline Pharma Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Richline Pharma Ltd
Richline Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1992 (34+ years old) and is registered under CIN U24239TG1992PLC014809.
Richline Pharma has 3 current directors:
- Subba Rao Yarapotina - Director
- Vijay Kumar Desa - Director
- Yerapotina Sri Ramesh Babu - Director
The CIN (Corporate Identification Number) of Richline Pharma is U24239TG1992PLC014809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Richline Pharma has 18 court cases on record: 11 filed by the company and 5 filed against it. 1 is pending. Most are in the high courts.
Richline Pharma was incorporated on 30 September 1992, making it 34+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vijay Kumar Desa was appointed as Director on 17 Jan 2007. Subba Rao Yarapotina was appointed as Director on 30 Sep 1992. Yerapotina Sri Ramesh Babu was appointed as Director on 30 Sep 1992.
The registered office of Richline Pharma is at 8 – 3 – 97793 Srinivasa Apts. Srinagar Colony, Hyderabad, Telangana, India – 500073.
Richline Pharma has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.18 Cr.
Richline Pharma operates in the pharma industry, in the drug formulation and development segment.
No. Richline Pharma is not listed on any stock exchange. It is an unlisted company.